Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
暂无分享,去创建一个
G. Frühbeck | F. Lopitz-Otsoa | M. Schwaninger | Amaia Rodríguez | V. Heras | R. Nogueiras | D. Guallar | Miguel Fidalgo | M. Varela-Rey | David Fernández-Ramos | P. Iruzubieta | J. Mato | J. Bilbao | Maria J. Gonzalez-Rellan | Cristina Ameneiro | A. Senra | Marcos F. Fondevila | Carlos Diéguez | Ganeko Bernardo | E. Nóvoa | V. Prévot | Tamara Parracho | C. Diéguez | M. Martínez‐Chantar | Ó. Millet | Javier Crespo | Natalia Lima | Susana Bravo | Maria DP. Chantada-Vazquez | F. Lopitz‐Otsoa | David Fernández‐Ramos | Violeta Heras | Susana B. Bravo | M. D. Chantada-Vazquez
[1] Q. Anstee,et al. A researcher's guide to preclinical mouse NASH models. , 2022, Nature metabolism.
[2] D. Vertommen,et al. The intra-mitochondrial O-GlcNAcylation system rapidly modulates OXPHOS function and ROS release in the heart , 2022, Communications Biology.
[3] C. Hoppel,et al. Blocked O-GlcNAc cycling alters mitochondrial morphology, function, and mass , 2021, Scientific Reports.
[4] Jie-Li Hu,et al. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis , 2021, Oncogene.
[5] D. Guallar,et al. A Simple, Rapid, and Cost-Effective Method for Loss-of-Function Assays in Pluripotent Cells. , 2021, Methods in molecular biology.
[6] Liteng Lin,et al. Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation. , 2021, Cancer letters.
[7] M. Roden,et al. The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments , 2021, Nature Reviews Gastroenterology & Hepatology.
[8] Jennifer M Aldridge Whitehead,et al. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. , 2021, Journal of hepatology.
[9] M. Mcphail,et al. Mitochondrial dysfunction as a mechanistic biomarker in patients with Non-Alcoholic fatty liver disease (NAFLD). , 2020, Mitochondrion.
[10] Shelly C. Lu,et al. Metabolic Landscape of the Mouse Liver by Quantitative 31P Nuclear Magnetic Resonance Analysis of the Phosphorome , 2020, Hepatology.
[11] H. Liu,et al. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation , 2020, Theranostics.
[12] R. Meex,et al. Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD , 2020, Molecular nutrition & food research.
[13] T. Lefebvre,et al. Editorial: O-GlcNAcylation: Expanding the Frontiers , 2019, Front. Endocrinol..
[14] D. Häussinger,et al. O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy. , 2019, Journal of hepatology.
[15] K. Cusi,et al. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options , 2019, JHEP reports.
[16] Q. Gao,et al. O‐GlcNAc transferase activates stem‐like cell potential in hepatocarcinoma through O‐GlcNAcylation of eukaryotic initiation factor 4E , 2019, Journal of cellular and molecular medicine.
[17] Jun Yu,et al. O-GlcNAc transferase suppresses necroptosis and liver fibrosis , 2019, bioRxiv.
[18] Xiaoyong Yang,et al. O-GlcNAc as an Integrator of Signaling Pathways , 2018, Front. Endocrinol..
[19] X. Zhang,et al. High glucose stimulates proliferative capacity of liver cancer cells possibly via O‐GlcNAcylation‐dependent transcriptional regulation of GJC1 , 2018, Journal of cellular physiology.
[20] Fenglin Liu,et al. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis. , 2018, Journal of hepatology.
[21] M. Masouminia,et al. Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis. , 2018, Experimental and molecular pathology.
[22] J. Banales,et al. O-GlcNAcylation: Undesired tripmate but an opportunity for treatment in NAFLD-HCC. , 2017, Journal of hepatology.
[23] Jun Yu,et al. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress. , 2017, Journal of hepatology.
[24] G. Shulman,et al. Regulation of hepatic glucose metabolism in health and disease , 2017, Nature Reviews Endocrinology.
[25] Xiaoyong Yang,et al. Protein O-GlcNAcylation: emerging mechanisms and functions , 2017, Nature Reviews Molecular Cell Biology.
[26] N. Zachara,et al. Stress-induced O-GlcNAcylation: an adaptive process of injured cells. , 2017, Biochemical Society transactions.
[27] G. Hart,et al. Roles of O-GlcNAc in chronic diseases of aging. , 2016, Molecular aspects of medicine.
[28] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[29] R. Huganir,et al. The nutrient sensor OGT in PVN neurons regulates feeding , 2016, Science.
[30] Damien Y. Duveau,et al. A small molecule that inhibits OGT activity in cells. , 2015, ACS chemical biology.
[31] T. Issad,et al. O‐GlcNAcylation of FoxO1 in pancreatic β cells promotes Akt inhibition through an IGFBP1‐mediated autocrine mechanism , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] D. Serra,et al. Mitochondrial fatty acid oxidation in obesity. , 2013, Antioxidants & redox signaling.
[33] G. Hart,et al. Regulation of Insulin Receptor Substrate 1 (IRS-1)/AKT Kinase-mediated Insulin Signaling by O-Linked β-N-Acetylglucosamine in 3T3-L1 Adipocytes* , 2009, The Journal of Biological Chemistry.
[34] W. V. So,et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance , 2008, Nature.
[35] Rohit Kohli,et al. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[36] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[37] R. Karim,et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.
[38] G. Hart,et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Drevon,et al. Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes. , 1986, Biochimica et biophysica acta.
[40] M. Horsch,et al. N-acetylglucosaminono-1,5-lactone oxime and the corresponding (phenylcarbamoyl)oxime. Novel and potent inhibitors of beta-N-acetylglucosaminidase. , 1991, European journal of biochemistry.